Rehabilitation Robots Market size was valued at USD 266.11 million in 2024 and is set to exceed USD 2.49 billion by 2037, registering over 18.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of rehabilitation robots is estimated at USD 352.18 million.
The growth of this market can be attributed to increasing medical conditions such as cumulative traumatic injuries, repetitive strain injuries, and occupational overuse syndromes. According to WHO, in 2021, approximately 1.71 billion people worldwide were suffering from diseases of the musculoskeletal system. Owing to the increasing number of people suffering from such conditions, rehabilitation robots are frequently used. These devices help disabled and disabled patients stand, balance and maintain ambulation.
Moreover, the increasing incidence of spinal cord injury is spurring the growth of rehabilitation robots, as the use of exoskeletons is recommended to improve the condition of spinal cord injury patients. This has been a major factor in the adoption of exoskeletons and therapeutic robots by patients and healthcare providers. According to the WHO, approximately 250,000 to 500,000 people worldwide suffer spinal cord injuries each year, and this rising number of patients has led to increased use of exoskeletons.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
18.8% |
|
Base Year Market Size (2024) |
USD 266.11 million |
|
Forecast Year Market Size (2037) |
USD 2.49 billion |
|
Regional Scope |
|
Type (Assistive, Therapeutic, Surgical, Exoskeleton Robot)
The exoskeleton robot segment is poised to dominate the global rehabilitation robots market by registering a CAGR of 38% in the time period between 2023-2036. Exoskeletons are designed to accelerate human strength and other medical capabilities. The increasing number of patients with physical movement disorders such as Parkinson's disease, stroke, etc. is a major factor accelerating the demand for exoskeletons as these diseases limit voluntary body movements and cause problems in daily routine activities. Robotic exoskeletons are emerging as rehabilitation tools to improve a variety of health-related outcomes after spinal cord injury. For instance, ReWalk is the first exoskeleton to receive FDA clearance for rehabilitation use in the United States. This robotic exoskeleton enables people with spinal cord injuries to stand, walk, roll over, and climb.
End-User (Hospital, Orphanage, Nursing Home)
The hospital segment in the rehabilitation robots market is set to hold the largest revenue share of 48% by the end of 2037. This growth is primarily due to rising healthcare costs and the rapid adoption of advanced technology in healthcare facilities. Additionally, a large population with musculoskeletal disorders, spinal cord injuries, etc. tend to move to hospitals for rehabilitation therapy, fueling the growth of this segment.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Patient Type |
|
|
End User |
|
North American Market Forecast
North America industry is poised to account for largest revenue share of 35% by 2037. This can be attributed on the back of the remarkable deployment of advanced technology in the region, combined with the growing healthcare sector. The International Federation of Robotics (IFR) release the World Robotics 2020 Industrial Robots report, which showed that 293,200 units of industrial robots were operating in factories in the United States in 2020. Meanwhile, 2.7 million industrial robots were operating in factories and industries around the world. Moreover, the rising FDA approvals for medical exoskeletons and rising awareness of technologically sophisticated systems would fuel market expansion in the region.
APAC Market Analysis
On the other hand, the market in the Asia Pacific region is anticipated to witness notable market growth of 27% over the estimated period on the back of noteworthy increment in the adoption of robots in each sector. Aging societies in the Asia-Pacific region, such as Japan and China, are driving the growth of the medical device and medical device testing industry, creating a huge market for rehabilitation robots in the region. Stroke is one of the leading causes of adult disability in China. This has led to increased awareness of robotic therapy and stimulated investment in this technology. In 2018, Avicrobot (a subsidiary of the Aviation Industry Corporation of China) developed a lower extremity rehabilitation robot. The company also collaborated with Xijing Hospital (China) to develop the robot. Together they founded the Rehabilitation Robot Research Center and provided data support for such robots.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?